Chen Y - Search Results

1

Antitumor activity of taspine by modulating the EGFR signaling pathway of Erk1/2 and Akt in vitro and in vivo.

Zhang Y, Zheng L, Zhang J, Dai B, Wang N, Chen Y, He L. Zhang Y, et al. Among authors: chen y. Planta Med. 2011 Nov;77(16):1774-81. doi: 10.1055/s-0030-1271132. Epub 2011 May 25. Planta Med. 2011. PMID: 21614750

2

Effects of taspine on proliferation and apoptosis by regulating caspase-3 expression and the ratio of Bax/Bcl-2 in A431 cells.

Zhang Y, Jiang Q, Wang N, Dai B, Chen Y, He L. Zhang Y, et al. Among authors: chen y. Phytother Res. 2011 Mar;25(3):357-64. doi: 10.1002/ptr.3268. Phytother Res. 2011. PMID: 20683843 No abstract available.

3

Activity of taspine isolated from Radix et Rhizoma Leonticis against estrogen-receptor-positive breast cancer.

Zhan Y, Zhang Y, Chen Y, Wang N, Zheng L, He L. Zhan Y, et al. Among authors: chen y. Fitoterapia. 2011 Sep;82(6):896-902. doi: 10.1016/j.fitote.2011.05.004. Epub 2011 May 14. Fitoterapia. 2011. PMID: 21605638

4

A novel taspine derivative, HMQ1611, inhibits breast cancer cell growth via estrogen receptor α and EGF receptor signaling pathways.

Zhan Y, Zhang Y, Liu C, Zhang J, Smith WW, Wang N, Chen Y, Zheng L, He L. Zhan Y, et al. Among authors: chen y. Cancer Prev Res (Phila). 2012 Jun;5(6):864-73. doi: 10.1158/1940-6207.CAPR-11-0575. Epub 2012 Apr 11. Cancer Prev Res (Phila). 2012. PMID: 22496388

5

A novel taspine derivative, HMQ1611, suppresses adhesion, migration and invasion of ZR-75-30 human breast cancer cells.

Zhan Y, Wang N, Liu C, Chen Y, Zheng L, He L. Zhan Y, et al. Among authors: chen y. Breast Cancer. 2014 May;21(3):334-40. doi: 10.1007/s12282-012-0392-8. Epub 2012 Aug 9. Breast Cancer. 2014. PMID: 22875642

6

Potentiation of paclitaxel activity by curcumin in human breast cancer cell by modulating apoptosis and inhibiting EGFR signaling.

Zhan Y, Chen Y, Liu R, Zhang H, Zhang Y. Zhan Y, et al. Among authors: chen y. Arch Pharm Res. 2014 Aug;37(8):1086-95. doi: 10.1007/s12272-013-0311-3. Epub 2013 Dec 10. Arch Pharm Res. 2014. PMID: 24318305

7

Functional and mechanistic analysis of telomerase: An antitumor drug target.

Chen Y, Zhang Y. Chen Y, et al. Pharmacol Ther. 2016 Jul;163:24-47. doi: 10.1016/j.pharmthera.2016.03.017. Epub 2016 Apr 23. Pharmacol Ther. 2016. PMID: 27118336 Review.

8

Targeting receptor tyrosine kinase EphB4 in cancer therapy.

Chen Y, Zhang H, Zhang Y. Chen Y, et al. Semin Cancer Biol. 2019 Jun;56:37-46. doi: 10.1016/j.semcancer.2017.10.002. Epub 2017 Oct 6. Semin Cancer Biol. 2019. PMID: 28993206 Review.

9

Application of the CRISPR/Cas9 System to Drug Resistance in Breast Cancer.

Chen Y, Zhang Y. Chen Y, et al. Adv Sci (Weinh). 2018 Apr 15;5(6):1700964. doi: 10.1002/advs.201700964. eCollection 2018 Jun. Adv Sci (Weinh). 2018. PMID: 29938175 Free PMC article. Review.

10

Mitochondrial reactive oxygen species cause major oxidative mitochondrial DNA damages and repair pathways.

Huang Z, Chen Y, Zhang Y. Huang Z, et al. Among authors: chen y. J Biosci. 2020;45:84. J Biosci. 2020. PMID: 32661211 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

180,064 results

Search Page

Filters